Protective Effect of Jianpiyifei II Granule against Chronic Obstructive Pulmonary Disease via NF-κB Signaling Pathway

Figure 3

Effects of JPYF II on inflammatory cells in BALF. (a) Total cells in BALF, (b) total macrophages in BALF, (c) total neutrophils in BALF, and (d) total lymphocytes in BALF. Control: saline-treated mice; model: LPS and CS-exposed mice; low: JPYF II (0.75 g/kg/d) + LPS and CS-exposed mice; middle: JPYF II (1.5 g/kg/d) + LPS and CS-exposed mice; high: JPYF II (3 g/kg/d) + LPS and CS-exposed mice; dexamethasone: dexamethasone (2 mg/kg/d) + LPS and CS-exposed mice. Values are presented as means ± SD. ^#P < 0.05 and ^###P < 0.001 compared with control mice; < 0.05, < 0.01, and < 0.001 compared with LPS and CS-exposed mice.

(a)

(b)

(c)

(d)